Page 25 - ீ குழு News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from ீ குழு. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In ீ குழு Today - Breaking & Trending Today
Serum Institute to provide 10 cr Covishield doses in June: Govt sources ANI | Updated: May 30, 2021 23:25 IST New Delhi [India], May 30 (ANI): The Government of India targets to procure 20 to 25 crore COVID-19 vaccine doses by July-end and 30 crore doses in August-September, informed government sources on Sunday. This came amid reports of shortage of COVID-19 vaccines in the country as flagged by several state governments. According to sources, the Serum Institute of India (SII) has initiated the process of ramping up the production of vaccine and will provide 10 crore doses of Covishield to the Central government by the next month and 10 to 12 crore doses by July. ....
Els crítics baixen a 261 (-9) i els ingressats a planta a 714 (-62), amb 668 nous positius i 8 morts La velocitat de propagació baixa a 0,95 ii la incidència acumulada en 14 dies també baixa a 112,74 ....
While individual disability income insurance products recorded a loss of $0.3 billion over the year to end March, 2021, this was a $1.1 billion improvement on last year’s figures, according to data. ....
The AAP on Friday alleged that the Centre is creating artificial scarcity of COVID-19 vaccines to benefit Bharat Biotech and Serum Institute of India, a charge termed by the Delhi BJP as unfounded . Addressing a press conference, AAP spokesperson Atishi said the government s vaccine drive has stopped in schools and this is the case throughout the country while in private hospitals, vaccination is still going on at different rates. India is currently using mainly two made-in India jabs â Covishield manufactured by the Serum Institute and Covaxin of Bharat Biotech â and Russian-made Sputnik V at a smaller scale to inoculate its population. ....
. and commercializing innovative immuno - oncology therapies and precision medicines, today . It has also been granted Breakthrough Therapy Designation by . ....